Home / Research library / KPV
KPV: molecular data, studies & sources
KPV is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C16H30N4O4
- Molecular weight (MW)
- 342.43 g/mol
- PubChem compound ID
- 125672
- Record title
- Msh (11-13)
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 125672 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid
- InChIKey
- YSPZCHGIWAQVKQ-AVGNSLFASA-N
- SMILES
- CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)N
Identifiers & sequence
- PubChem CID
- 125672
- CAS Registry Number
- 67727-97-3via ChemIDplus, EPA DSSTox
- InChIKey
- YSPZCHGIWAQVKQ-AVGNSLFASA-N
- Wikidata
- Q82975228
Peptide sequence · 3 residues (one-letter code; X marks a residue without a one-letter code)
KPV
Condensed notation with terminal groups and non-standard residues
H-Lys-Pro-Val-OH
Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.
CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 342.2267 Da |
|---|---|
| Heavy atoms | 24 |
| Hydrogen-bond donors | 4 |
| Hydrogen-bond acceptors | 5 |
| Rotatable bonds | 9 |
| Topological polar surface area | 138.8 Ų |
| Calculated logP (Crippen) | -0.34 |
| Rings | 1 |
| Stereocenters | 3 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list KPV as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received KPV, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Research publication · design requires review
alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.
Elliott RJ, Szabo M, Wagner MJ et al. · The Journal of investigative dermatology · 2004
PMID 15102092 · DOI: 10.1111/j.0022-202X.2004.22404.x
- Preclinical / laboratory research
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.
Zhao Y, Xue P, Lin G et al. · Acta biomaterialia · 2022
PMID 35245681 · DOI: 10.1016/j.actbio.2022.02.039
- Research publication · design requires review
Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.
Pawar K, Kolli CS, Rangari VK et al. · Journal of pharmaceutical sciences · 2017
PMID 28343991 · DOI: 10.1016/j.xphs.2017.03.017
- Preclinical / laboratory research
Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.
Getting SJ, Schiöth HB, Perretti M et al. · The Journal of pharmacology and experimental therapeutics · 2003
PMID 12750433 · DOI: 10.1124/jpet.103.051623
- Research publication · design requires review
KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy.
Zhang L, Li D, Aierken Y et al. · Advanced healthcare materials · 2024
PMID 39252648 · DOI: 10.1002/adhm.202402320
- Research publication · design requires review
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.
Dalmasso G, Charrier-Hisamuddin L, Nguyen HT et al. · Gastroenterology · 2007
PMID 18061177 · DOI: 10.1053/j.gastro.2007.10.026
- Preclinical / laboratory research
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.
Kannengiesser K, Maaser C, Heidemann J et al. · Inflammatory bowel diseases · 2008
PMID 18092346 · DOI: 10.1002/ibd.20334
- Preclinical / laboratory research
Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats.
Sun J, Xue P, Liu J et al. · ACS biomaterials science & engineering · 2021
PMID 34547895 · DOI: 10.1021/acsbiomaterials.1c00792
KPV supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
KPV for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| American PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $60.00Checked Nov 6, 2026Supplier listing, KPV 10mg Vial, American Peptides, opens in a new tab |
| Blank PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $45.00Stale observation · Checked Sep 30, 2026Supplier listing, KPV 10mg Vial, Blank Peptides, opens in a new tab |
| Amino ClubUSD | 10mg Vial1 recorded offers | 10mg Vial · $39.99Stale observation · Checked Oct 14, 2026Supplier listing, KPV 10mg Vial, Amino Club, opens in a new tab |
| Nova Peptide SupplyUSD | 10mg Vial1 recorded offers | 10mg Vial · $49.99Checked Nov 6, 2026Supplier listing, KPV 10mg Vial, Nova Peptide Supply, opens in a new tab |
| Amino USAUSD | 10mg Vial · 5mg Vial2 recorded offers | 10mg Vial · $50.00Checked Nov 6, 2026Supplier listing, KPV 10mg Vial, Amino USA, opens in a new tab |
| Cenexa LabsUSD | 10mg Vial1 recorded offers | 10mg Vial · $69.99Checked Nov 6, 2026Supplier listing, KPV 10mg Vial, Cenexa Labs, opens in a new tab |
| LA PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $59.99Checked Nov 3, 2026Supplier listing, KPV 10mg Vial, LA Peptides, opens in a new tab |
Reference sources & further reading
- PubChem compound record 125672 — chemical identity and structure.
- Wikipedia: KPV tripeptide — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
AOD-9604
C78H123N23O23S2
1815.1 g/mol · PubChem CID 71300630
2 selected publications · 0 human intervention studies
ARA-290
C51H84N16O21
1257.3 g/mol · PubChem CID 91810664
7 selected publications · 3 human intervention studies · 2 registered trials
Protein / peptide · highest stage: Phase 2
BPC-157
C62H98N16O22
1419.5 g/mol · PubChem CID 9941957
7 selected publications · 1 human intervention study · 3 registered trials
Protein / peptide · highest stage: Phase 1
LL-37
C205H340N60O53
4493 g/mol · PubChem CID 16198951
4 selected publications · 0 human intervention studies · 2 registered trials
PTD-DBM
Molecular identity needs further verification
3 selected publications · 0 human intervention studies
TB-500
Molecular identity needs further verification
1 selected publication · 0 human intervention studies · 1 registered trial